Scientific Literature Search

Source record

Osteoporosis and Parkinson's disease.

Raglione LM, Sorbi S, Nacmias B.

Clin Cases Miner Bone Metab · 2011-09-01

PMID: 22461823

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson's disease and α-synuclein expression.

Devine MJ, Gwinn K, Singleton A, Hardy J.

Mov Disord · 2011-09-01

DOI: 10.1002/mds.23948PMID: 21887711

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Purinergic signalling: from normal behaviour to pathological brain function.

Burnstock G, Krügel U, Abbracchio MP, Illes P.

Prog Neurobiol · 2011-09-01

DOI: 10.1016/j.pneurobio.2011.08.006PMID: 21907261

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.

Jenner P, McCreary AC, Scheller DK.

J Neural Transm (Vienna) · 2011-09-01

DOI: 10.1007/s00702-011-0703-9PMID: 21881838

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Iravani MM, Jenner P.

J Neural Transm (Vienna) · 2011-09-01

DOI: 10.1007/s00702-011-0698-2PMID: 21881839

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.

Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou SF, Chauhan A, Kanwar RK.

Nanomedicine · 2011-09-01

DOI: 10.1016/j.nano.2011.08.006PMID: 21889479

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Anxiety in Parkinson's disease: a critical review of experimental and clinical studies.

Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA.

Neuropharmacology · 2011-08-31

DOI: 10.1016/j.neuropharm.2011.08.039PMID: 21903105

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The CDK inhibitors in cancer research and therapy.

Cicenas J, Valius M.

J Cancer Res Clin Oncol · 2011-08-30

DOI: 10.1007/s00432-011-1039-4PMID: 21877198

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Sleep-wake changes in the premotor stage of Parkinson disease.

Iranzo A.

J Neurol Sci · 2011-08-30

DOI: 10.1016/j.jns.2011.07.049PMID: 21880334

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Imaging biomarkers in Parkinson's disease.

Brooks DJ, Pavese N.

Prog Neurobiol · 2011-08-30

DOI: 10.1016/j.pneurobio.2011.08.009PMID: 21896306

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.

Amin N, Byrne E, Johnson J, Chenevix-Trench G, Walter S, Nolte IM, kConFab Investigators, Vink JM, Rawal R, Mangino M, Teumer A, Keers JC, Verwoert G, Baumeister S, Biffar R, Petersmann A, Dahmen N, Doering A, Isaacs A, Broer L, Wray NR, Montgomery GW, Levy D, Psaty BM, Gudnason V, Chakravarti A, Sulem P, Gudbjartsson DF, Kiemeney LA, Thorsteinsdottir U, Stefansson K, van Rooij FJ, Aulchenko YS, Hottenga JJ, Rivadeneira FR, Hofman A, Uitterlinden AG, Hammond CJ, Shin SY, Ikram A, Witteman JC, Janssens AC, Snieder H, Tiemeier H, Wolfenbuttel BH, Oostra BA, Heath AC, Wichmann E, Spector TD, Grabe HJ, Boomsma DI, Martin NG, van Duijn CM.

Mol Psychiatry · 2011-08-30

DOI: 10.1038/mp.2011.101PMID: 21876539

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dopamine cell transplantation in Parkinson's disease: challenge and perspective.

Ma Y, Peng S, Dhawan V, Eidelberg D.

Br Med Bull · 2011-08-28

DOI: 10.1093/bmb/ldr040PMID: 21875864

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

41.540 articles found

Osteoporosis and Parkinson's disease.

Parkinson's disease and α-synuclein expression.

Purinergic signalling: from normal behaviour to pathological brain function.

Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.

Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.

Anxiety in Parkinson's disease: a critical review of experimental and clinical studies.

The CDK inhibitors in cancer research and therapy.

Sleep-wake changes in the premotor stage of Parkinson disease.

Imaging biomarkers in Parkinson's disease.

Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM.

Dopamine cell transplantation in Parkinson's disease: challenge and perspective.

Filters